Psychiatric Documentation and Management in Primary Care With Artificial Intelligence Scribe Use.
AI scribes enhance psychiatric documentation but reduce intervention likelihood in primary care. Key findings from JAMA Psychiatry study. 📊🧠
Molecular mechanisms and therapeutic progress in atherosclerosis: bridging immune inflammation and precision medicine.
Molecular mechanisms in atherosclerosis reveal new therapies: immunomodulatory vaccines, RNA therapeutics, and AI integration. 🩺💉📊
NHS App to Serve as Central Hub for Preventative Healthcare
NHS App aims to enhance preventative healthcare access. 🌐 It will support vaccinations, screenings, and health checks for better community health. 💉
Development and Evaluation of an AI Avatar Educational Tool for Depression and Anxiety: A Qualitative Pilot Study.
AI avatars enhance education on depression and anxiety, achieving 90% credibility and 85% satisfaction in pilot study. 📊🤖
Interpretable Machine Learning for Survival Prediction in Small Cell Lung Cancer Patients With Brain Metastases: A Population-Based Study With External Validation.
Machine learning predicts survival in small cell lung cancer with brain metastases. RSF model shows AUCs up to 0.809! 📊🧠
Norfolk and Waveney Postpones EPR Implementation to Ensure Quality
Norfolk and Waveney delays EPR system launch to ensure quality. New go-live date set for spring 2027. 🏥📅
Integrating Artificial Intelligence in Nursing Practice With Decubitus Risk Prediction Alerts: A Pilot Process Evaluation.
AI in Nursing: 30% of patients identified at risk for pressure ulcers. Feasibility confirmed with 80% adherence to care plans. 🤖🩺
Usability-Related Barriers and Facilitators Influencing the Adoption and Use of AI Scribes in Healthcare: A Scoping Review.
AI Scribes in Healthcare: Balancing Benefits and Usability Challenges 🤖📋
Aneurin Bevan University Health Board Implements Clinisys WinPath for Blood Transfusion Services
Aneurin Bevan University Health Board adopts Clinisys WinPath for blood transfusion services, enhancing efficiency and user experience. 🩸💻
Development of Betalactam-Predictor: A Clinical Decision Tool for Delabeling Low-Risk Betalactam Allergy Patients. Initial Validation in Penicillin Allergy.
New tool predicts low-risk betalactam allergies with 93% specificity! 🤖📊 Study on 6468 patients shows promise for delabeling.